Verrill's patent attorneys specialize in assisting biotech and life science clients at every level from university research, to startups, to mid-market and large corporations. We understand the challenges of leveraging funding for product development from dynamic research programs in a competitive environment. We're experienced in US and foreign patent prosecution, patent litigation, post-grant proceedings, opinions related to non-infringement, invalidity, freedom to operate, inventorship disputes, licensing, portfolio analysis, and competitor analysis.
Our patent prosecutors have extensive experience dealing with patent eligibility matters and work with a wide array of technologies including the following:
- Antibodies
- Aptamers
- Aquaculture
- Biofuels
- Cancer therapies and vaccines
- CAR T-cells
- Cell culture
- Chromatography systems
- CRISPR technology
- Drug delivery vehicles
- Drug formulation
- ELISA
- Fluorescence in situ hybridization
- Food science and enzymes
- Gene therapy
- Genetic adjuvants
- Genomics
- Immunotherapeutics
- Industrial chemical and biochemical processes
- Medical diagnostics
- Microscopy technology and image analysis
- Modular agricultural systems
- Nanoparticles
- Nucleic acids
- Nutritional biochemistry
- Probes
- Proteins
- Sequencing technology
- Small molecule pharmaceuticals
- Spectrometry
- Stem cells
- Targeting of drugs and biologics
- Test kits
- Transgenic animals
- Treatment of diabetes and metabolic diseases
- Viral vectors
Examples of how our patent attorneys have helped their biotech clients include:
- Quickly established a patent portfolio in the competitive CAR T-cell space to support funding efforts of a biotech startup.
- Assisted an instrumentation company in an inventorship dispute with its research collaborator, resulting in the company establishing its own patent portfolio.
- Obtained broad patent coverage for a biologics formulations company to support its partnering efforts.
